07:00 , Apr 6, 2009 |  BC Week In Review  |  Company News

Beckman Coulter, Clinical Data deal

Clinical Data will sell its Cogenics Inc. genomics services division to Beckman Coulter for $17 million in cash. Cogenics provides sequencing, gene expression, genotyping, biomanufacturing support, nucleic acid extraction and biobanking services. Beckman Coulter plans...
08:00 , Jan 8, 2009 |  BC Innovations  |  Targets & Mechanisms

Gazing deeper into cancer

Three recent genomic studies in glioblastoma multiforme,1 acute myeloid leukemia2 and lung adenocarcinoma3reveal potential new drug targets and provide a next step toward personalized, whole genome-based cancer diagnostics. Genomic sequencing could provide more robust data...
07:00 , Oct 22, 2007 |  BC Week In Review  |  Company News

Agencourt, Invitrogen, Illumina, Via Pharmaceuticals deal

The parties will participate in a research project to develop a 5-lipoxygenase genotyping panel and an ADMET panel for use in an ongoing Phase II trial of VIAP's VIA-2291 in patients at risk...
07:00 , Apr 30, 2007 |  BC Week In Review  |  Company News

Affymetrix, Beckman Coulter, NuGen sales and marketing update

The companies will combine certain RNA blood chemistry technologies from BEC's Agencourt Bioscience subsidiary with NuGen's Ovation RNA amplification solution using automation methods developed by Array Automation, a JV between BEC and AFFX. The service...
07:00 , Aug 7, 2006 |  BC Week In Review  |  Company News

Beckman Coulter sales and marketing update

BEC launched its Agencourt RNAdvance tissue system to isolate RNA from mammalian samples. The RNAdvance tissue process is based on the Agencourt SPRI (Solid Phase Reversible Immobilization) paramagnetic bead nucleic acid purification technology. Beckman Coulter...
07:00 , Jul 17, 2006 |  BC Week In Review  |  Company News

Beckman Coulter sales and marketing update

BEC launched its Agencourt FormaPure system for automated extraction of DNA and RNA from formalin-fixed, paraffin-embedded tissue samples. Beckman Coulter Inc. (BEC), Fullerton, Calif.   Business: Supply/Service   ...
07:00 , Jul 17, 2006 |  BC Week In Review  |  Company News

Agencourt Personal Genomics, Applied Biosystems deal

Instrument company ABI completed its previously announced acquisition of Agencourt for about $120 million in cash (see BioCentury, June 5). Agencourt uses parallel fluorescence sequencing for high throughput nucleic acid analysis. Agencourt was spun out...
07:00 , Jun 12, 2006 |  BioCentury  |  Tools & Techniques

Sequencing stimulant

Leapfrogging is the name of the game in the supplier space, even if new tools cannibalize one's own products. Thus Applied Biosystems Group hopes its $120 million acquisition of Agencourt Personal Genomics will give it...
07:00 , Jun 5, 2006 |  BC Week In Review  |  Company News

Agencourt Personal Genomics, Applied Biosystems deal

Instrument company ABI plans to acquire Agencourt for $120 million in cash. Agencourt uses parallel fluorescence sequencing for high throughput nucleic acid analysis, which ABI said complements its platforms for high throughput genotyping, high throughput...
00:47 , May 31, 2006 |  BC Extra  |  Top Story

ABI acquiring Agencourt spinout

Instrument company Applied Biosystems (ABI) plans to acquire Agencourt Personal Genomics (Beverly, Mass.) for $120 million in cash. Agencourt uses parallel fluorescence sequencing for high throughput nucleic acid analysis, which ABI said complements its platforms...